晚发性作为一种前兆症状
1Epileptology Unit, Reference Center for Rare Epilepsies, Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France; Rehabilitation Unit, Pitié-Salpêtrière Hospital, AP-HP, Paris, France; Paris Brain Institute (ICM), FrontLab, Sorbonne-Université, Inserm U1127, CNRS 7225, 75013 Paris, France; Université Paris Sorbonne, Paris, France.
Revue neurologique
|November 14, 2025
概括
晚发性 (LOE) 可能是早期神经系统疾病的信号,如中风或阿尔茨海默病 (AD). 对心血管风险和认知衰退的早期干预对于管理这些疾病至关重要.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 老年病的医生 老年病的医生
背景情况:
- 15-30%的晚发性 (LOE) 病例有未知的原因.
- 无法解释的发作可能表明中风或阿尔茨海默病 (AD) 的早期阶段.
- 共同的心血管风险因素可能会将LOE,中风和AD联系起来.
研究的目的:
- 探索无法解释的LOE与潜在的神经疾病之间的联系.
- 评估LOE作为中风和AD潜在的前兆标志的作用.
- 评估当前的管理策略,并确定早期干预的需求.
主要方法:
- 审查当前证据,将发作与脑血管疾病和神经退行症联系起来.
- 对共享风险因素假设的分析.
- 对LOE.建议的诊断和管理方法的讨论.
主要成果:
- 发作可能会先于中风或AD的临床表现.
- 有证据表明,发作反映了早期的病理变化,如粉样蛋白β和沉积.
- 目前的建议包括对不明原因的LOE进行心血管评估和认知评估.
结论:
- 无法解释的LOE需要对潜在的中风或AD进行调查.
- 综合的心血管管理和认知评估是必不可少的.
- 突发性发作为早期干预提供了一个窗口,以减缓神经退行.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Potassium Channel Activators
616
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
616
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists
876
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
876
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
802
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
802


